Philadelphia Mass Tort Group Xarelto Lawsuits Claim Drug Can Cause Uncontrollable Bleeding

January 29, 2016 – – BloodThinnerHelp.com reports on regularly increasing case numbers consolidated to form a mass tort group from Philadelphia, PA by the Philadelphia Court of Common Pleas. The cases were commonly filed against defendants Bayer AG and Janssen Pharmaceuticals, (a division of Johnson & Johnson corporation). All plaintiffs who have filed commonly claim that anticoagulant Xarelto can put users at increased risk for spontaneous uncontrollable bleeding episodes and other serious side effects. At this time, the cases involved in the mass tort group reportedly number over 550. hey are currently in pretrial and discovery stages, and other cases may still join them.

The plaintiffs involved in these lawsuits are not alone in their allegations. They are joined by over 2,800 other plaintiffs who have filed similar lawsuits in federal courts across the nation. These federally filed cases were consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL No. 2592 in Louisiana. This was possible due to the fact that, again, all cases contained similar allegations against the same two defendants, manufacturers of blood thinning drug Xarelto. Plaintiffs agree that the manufacturers were recklessly negligent to release their drug to the public with no accompanying antidote.

The fact that Xarelto has no corresponding antidote means that when a patient who has taken the blood thinner develops even a minor bleeding injury, (either internal or external), that bleed can quickly become uncontrollable, due to the fact that the drug will prevent physicians from being able to clot the blood. In these circumstances, doctors are required to resort to extreme life-saving measures such as surgeries and blood transfusions.

Traditional blood thinners, such as warfarin, were released to the public with an accompanying antidote through vitamin K. Although this requires that patients using this blood thinner to follow special diets, it also allows them to have a potentially life-saving option in emergency bleeding situations. When these patients are injured, a doctor can treat them with vitamin K which will counter the drug’s blood-thinning effects and clot their blood.

Attorney Joseph Osborne is hoping to help ensure that all people who may have been negatively affected by Xarelto will have the opportunity to explore their legal rights in full. Those who have used the blood thinner and subsequently suffered from health problems may be entitled to compensation. Attorney Osborne is currently offering free legal consultations to involved parties.

To ask questions or request more information, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60007810